Infectious Disease Flashcards
Urinary tract infections
Lower urinary tract infections (UTIs) involve infection in the bladder, causing cystitis (inflammation of the bladder).
Pyelonephritis refers to inflammation of the kidney resulting from bacterial infection. The inflammation affects the kidney tissue (parenchyma) and the renal pelvis (where the ureter joins the kidney).
Urinary tract infections are far more common in women, where the urethra is much shorter, making it easier for bacteria to get into the bladder.
The primary source of bacteria for urinary tract infections is faeces. Normal intestinal bacteria, such as E. coli, can easily journey to the urethral opening from the anus. Sexual activity is a crucial method for spreading bacteria around the perineum. Incontinence or poor hygiene can also contribute to the development of UTIs.
Urinary catheters are a possible source of infection, and catheter-associated urinary tract infections tend to be more serious and challenging to treat.
Presentation of UTIs
Lower urinary tract infections present with:
Dysuria (pain, stinging or burning when passing urine)
Suprapubic pain or discomfort
Frequency
Urgency
Incontinence
Haematuria
Cloudy or foul-smelling urine
Confusion is commonly the only symptom in older and frail patients
Pyelonephritis has a similar presentation to lower urinary tract infections plus the additional triad of symptoms:
Fever
Loin or back pain (bilateral or unilateral)
Nausea or vomiting
Patients with pyelonephritis may also have:
Systemic illness
Loss of appetite
Haematuria
Renal angle tenderness on examination
TOM TIP: It is essential to distinguish between lower urinary tract infections and pyelonephritis. Pyelonephritis is a more severe condition with significant complications, including sepsis and kidney scarring. Suspect pyelonephritis in patients with:
Fever
Loin or back pain
Nausea or vomiting
Renal angle tenderness on examination
Urine dipstick
Nitrites on a dipstick test suggest bacteria in the urine. Gram-negative bacteria (e.g., E. coli) break down nitrates (a normal waste product in urine) into nitrites.
Leukocytes are white blood cells. It is normal to have a small number of leukocytes in the urine, but a significant rise can result from an infection or other cause of inflammation. Leukocyte esterase (a product of leukocytes) is tested on a urine dipstick, indicating the number of leukocytes in the urine.
Red blood cells in the urine indicate bleeding. Microscopic haematuria is where blood is seen on a urine dipstick but not seen when looking at the sample. Macroscopic haematuria is where blood is visible in the urine. Haematuria is a common sign of infection but can also be present with other causes, such as bladder cancer or nephritis.
Nitrites are a better indication of infection than leukocytes. The NICE clinical knowledge summaries (June 2023) suggest that nitrites or leukocytes plus red blood cells indicate that the patient will likely have a UTI. The dipstick result is less reliable in catheterised patients or women over 65.
Where only nitrites are present, it is worth treating as a UTI. Where only leukocytes are present, a sample should be sent to the lab for further testing. Antibiotics may be considered where there is clinical evidence of a UTI.
A midstream urine (MSU) sample sent for microscopy, culture and sensitivity testing will determine the infective organism and the antibiotics that will be effective in treatment. Not all patients with an uncomplicated UTI require an MSU. An MSU is important in:
Pregnant patients
Patients with recurrent UTIs
Atypical symptoms
When symptoms do not improve with antibiotics
Causes of UTIs
The most common cause of UTI is Escherichia coli, which are gram-negative, anaerobic, rod-shaped bacteria. They are part of the lower intestinal microbiome and can easily spread from faeces to the bladder.
Other causes:
Klebsiella pneumoniae (gram-negative, anaerobic, rod-shaped bacteria)
Enterococcus
Pseudomonas aeruginosa
Staphylococcus saprophyticus
Candida albicans (fungal)
Managing lower UTIs
Follow local guidelines. An appropriate initial antibiotic in the community would be:
Nitrofurantoin (avoided in patients with an eGFR <45)
Trimethoprim (often associated with high rates of bacterial resistance)
Alternatives:
Pivmecillinam
Amoxicillin
Cefalexin
The typical duration of antibiotics is:
3 days of antibiotics for simple lower urinary tract infections in women
5-10 days of antibiotics for immunosuppressed women, abnormal anatomy or impaired kidney function
7 days of antibiotics for men, pregnant women or catheter-related UTIs
It is worth noting that NICE recommend changing the catheter when someone is diagnosed with a catheter-related urinary tract infection.
Managing pyelonephritis
Referral to hospital is required if there are features of sepsis or if it is unsafe to manage them in the community.
NICE guidelines (2018) recommend the following first-line antibiotics for 7-10 days when treating pyelonephritis in the community:
Cefalexin
Co-amoxiclav (if culture results are available)
Trimethoprim (if culture results are available)
Ciprofloxacin (keep tendon damage and lower seizure threshold in mind)
Patients admitted to hospital with sepsis require the sepsis six, which includes a serum lactate, blood cultures, urine output monitoring, oxygen, empirical broad-spectrum antibiotics and IV fluids.
Two things to keep in mind with patients that have significant symptoms or do not respond well to treatment are:
Renal abscess
Kidney stone obstructing the ureter, causing pyelonephritis
Pregnancy and UTIs
Urinary tract infections in pregnancy increase the risk of pyelonephritis, premature rupture of membranes and pre-term labour.
Managing UTIs in pregnancy
Urinary tract infection in pregnancy requires 7 days of antibiotics. All women should have an MSU for microscopy, culture and sensitivity testing.
The antibiotic options are:
Nitrofurantoin (avoided in the third trimester)
Amoxicillin (only after sensitivities are known)
Cefalexin (the typical choice)
Nitrofurantoin should be avoided in the third trimester as there is a risk of neonatal haemolysis (destruction of the neonatal red blood cells).
Trimethoprim should be avoided in the first trimester as it works as a folate antagonist. Folate is essential in early pregnancy for the normal development of the fetus. Trimethoprim in early pregnancy can cause congenital malformations, particularly neural tube defects (e.g., spina bifida). It is not known to be harmful later in pregnancy but is generally avoided unless necessary.
Cellulitis
Cellulitis is an infection of the skin and the soft tissues underneath. The skin forms a physical barrier between the environment and soft tissues. When a patient presents with cellulitis, look for a breach in the skin barrier and a point of entry for the bacteria. This may be due to skin trauma, eczema, fungal nail infections or ulcers.
Presentation of cellulitis
Skin changes in cellulitis include:
Erythema (red discolouration)
Warm or hot to touch
Tense
Thickened
Oedematous
Bullae (fluid-filled blisters)
A golden-yellow crust indicates a Staphylococcus aureus infection
Patients may be systemically unwell, including having sepsis.
Causes of cellulitis
The most common causes are:
Staphylococcus aureus
Group A streptococcus (mainly streptococcus pyogenes)
Group C streptococcus (mainly streptococcus dysgalactiae)
MRSA should be considered, particularly in patients the repeated hospital admissions and antibiotics.
Severity of cellulitis
The Eron classification assesses the severity of cellulitis:
Class 1 – no systemic toxicity or comorbidity
Class 2 – systemic toxicity or comorbidity
Class 3 – significant systemic toxicity or significant comorbidity
Class 4 – sepsis or life-threatening infection
Managing cellulitis
Class 3 and 4 cellulitis requires admission for intravenous antibiotics. Admission is also considered for frail, very young or immunocompromised patients and those with facial, periorbital or orbital cellulitis.
Flucloxacillin is the usual first-line antibiotic for cellulitis, either oral or intravenous. It is particularly effective against Staphylococcus aureus and also works well against other gram-positive cocci.
Alternatives:
Clarithromycin
Clindamycin
Co-amoxiclav (the usual first choice for cellulitis near the eyes or nose)
Bacteria and ENT infections
Bacterial tonsillitis is most commonly caused by group A streptococcus (GAS) infections, mainly streptococcus pyogenes.
Otitis media, sinusitis and tonsillitis not caused by GAS are most commonly caused by:
Streptococcus pneumoniae
Other causes of otitis media, sinusitis and tonsillitis:
Haemophilus influenzae
Moraxella catarrhalis
Staphylococcus aureus
Tonsillitis
The Centor criteria can be used to estimate the probability that tonsillitis is due to bacterial infection and will benefit from antibiotics. A score of 3 or more gives a 40 – 60 % probability of bacterial tonsillitis, and it is appropriate to offer antibiotics. A point is given if each of the following features are present:
Fever over 38ºC
Tonsillar exudates
Absence of cough
Tender anterior cervical lymph nodes (lymphadenopathy)
The FeverPAIN score is an alternative to the Centor criteria. A score of 2 – 3 gives a 34 – 40% probability, and 4 – 5 gives a 62 – 65% probability of bacterial tonsillitis:
Fever during the previous 24 hours
P – Purulence (pus on tonsils)
A – Attended within 3 days of the onset of symptoms
I – Inflamed tonsils (severely inflamed)
N – No cough or coryza
Treating tonsillitis
Penicillin V (phenoxymethylpenicillin) for a 10-day course is typically first-line. It has a relatively narrow spectrum of activity and is effective against Streptococcus pyogenes.
Clarithromycin is the usual first-line choice in true penicillin allergy.
Complications of tonsillitis
Peritonsillar abscess, also known as quinsy
Otitis media, if the infection spreads to the inner ear
Scarlet fever
Rheumatic fever
Post-streptococcal glomerulonephritis
Post-streptococcal reactive arthritis
Otitis Media
Otitis media presents with reduced hearing and pain in the affected ear. Otoscopy will reveal a bulging red tympanic membrane. A perforated tympanic membrane can result in discharge from the ear.
Otitis media usually resolves within 3 to 7 days without antibiotics. Systemically unwell may need admission.
Treating Otitis Media
The NICE clinical knowledge summaries (updated May 2023) suggest:
Amoxicillin for 5-7 days first-line
Clarithromycin (if penicillin allergic)
Erythromycin (in pregnant women allergic to penicillin)
Co-amoxiclav is a second-line option if the infection is not responding to amoxicillin.
Sinusitis
Sinusitis is usually viral. Only around 2% of acute sinusitis is bacterial. Sinusitis typically last 2-3 weeks and resolves without treatment.
Treating Sinusitis
NICE CKS (May 2023) recommend for patients with symptoms that are not improving after 10 days, the options of:
High-dose steroid nasal spray for 14 days (e.g., mometasone 200 mcg twice daily)
A backup antibiotic prescription, used if worsening or not improving within 7 days (phenoxymethylpenicillin first-line)
The options for chronic sinusitis (lasting more than 12 weeks) are:
Saline nasal irrigation
Steroid nasal sprays or drops (e.g., mometasone or fluticasone)
Functional endoscopic sinus surgery (FESS)
Intra-abdominal infections
Acute diverticulitis (infection in intestinal diverticula)
Acute cholecystitis (with secondary infection in the gallbladder)
Ascending cholangitis (infection in the bile ducts)
Appendicitis (infection in the appendix)
Spontaneous bacterial peritonitis (infection in the fluid in the peritoneal cavity)
Intra-abdominal abscess
Bacterial causes of intra-abdominal infections
Anaerobes (e.g., Bacteroides and Clostridium)
E. coli (gram-negative)
Klebsiella (gram-negative)
Enterococcus (gram-positive)
Streptococcus (gram-positive)
Antibiotics and intra-abdominal infections
Intra-abdominal infections require broad-spectrum antibiotics until culture results are available. Antibiotics need to cover gram-positive, gram-negative and anaerobic bacteria.
Co-amoxiclav provides good gram-positive, gram-negative and anaerobe cover. It does not cover pseudomonas or atypical bacteria.
Quinolones (e.g., ciprofloxacin and levofloxacin) provide gram-positive, gram-negative and atypical cover. However, they do not cover anaerobes, so they are usually paired with metronidazole for intra-abdominal infections.
Metronidazole provides excellent anaerobe cover but does not provide any cover against aerobic bacteria.
Gentamicin provides excellent gram-negative cover and some gram-positive cover (particularly against staph). It is bactericidal, killing bacteria rather than just slowing them down.
Vancomycin provides excellent gram-positive cover, including MRSA. It is often combined with gentamicin (for gram-negative cover) and metronidazole (for anaerobe cover) in patients with penicillin allergy.
Cephalosporins provide good broad-spectrum cover against gram-positive and gram-negative bacteria but are not very effective against anaerobes. They are often avoided due to the risk of Clostridium difficile (C. diff) infection.
Piperacillin with tazobactam (tazocin) and meropenem are powerful antibiotics that cover gram-positive, gram-negative and anaerobic bacteria. They do not cover atypical bacteria or MRSA. Tazocin does not cover ESBLs. They are usually reserved for very unwell patients and those not responding to other antibiotics.
Local antibiotic policies will determine the choice based on local resistance and infection control issues. Typical regimes for treating intra-abdominal infection are: